 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
LifeMD, Inc. (LFMD) operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.
The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.
It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more.
In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses.
It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels.
The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
Please note, this stock reported earnings on Monday, March 11th.
LifeMD reported a loss of $0.12 per share on revenue of $44.86 million for the fourth quarter ended December 2023. The consensus estimate was a loss of $0.14 per share on revenue of $40.65 million. The company beat consensus estimates by 14.29% while revenue grew 59.53% on a year-over-year basis.
The company said it expects first quarter revenue of $42.0 million to $43.0 million and revenue of at least $200.0 million. The company's previous guidance was 2024 revenue of $195.0 million to $205.0 million. The current consensus revenue estimate is $42.85 million for the quarter ending March 31, 2024 and revenue of $193.10 million for the year ending December 31, 2024.
After a strong earnings report, share prices should head higher.
Entry Point: $10.75
Trading Range: $1.20 - $11.06
Stop Loss: $10.20
Target Price: $11.80
LFMD closed at $9.95
